Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer

被引：0
|
作者：
Hyo Jin Lee
Do Yeun Cho
Ji Chan Park
Sang Byung Bae
Kyu Taek Lee
In Sung Cho
Chang Soon Han
Suk Young Park
Hwan Jung Yun
Samyong Kim
机构：
[1] Chungnam National University Hospital,Division of Hematology/Oncology, Department of Internal Medicine
[2] Konyang University Hospital,Department of Internal Medicine
[3] Daejeon St. Mary’s Hospital,Department of Internal Medicine
[4] Soon Chun Hyang University Cheonan Hospital,Department of Internal Medicine
[5] Eulji University Hospital,Department of Internal Medicine
[6] Cheongju St. Mary’s Hospital,Department of Internal Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 63卷
关键词：
Gastric cancer; Paclitaxel; 5-Fluorouracil; Leucovorin; Biweekly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer
    Popov, I.
    Radosevic-Jelic, L.
    Jezdic, S.
    Milovic, M.
    Borojevic, N.
    Stojanovic, S.
    Stankovic, V.
    Josifovski, T.
    Kezic, I.
    JOURNAL OF BUON, 2008, 13 (04): : 505 - 511
  • [42] Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer
    Agustin A. Garcia
    Lawrence Leichman
    Joaquina Baranda
    Lalita Pandit
    Heinz-Josef Lenz
    Cynthia G. Leichman
    International Journal of Gastrointestinal Cancer, 2003, 34 (2-3): : 79 - 86
  • [43] Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer
    Kemeny, N
    Garay, CA
    Gurtler, J
    Hochster, H
    Kennedy, P
    Benson, A
    Brandt, DS
    Polikoff, J
    Wertheim, M
    Shumaker, G
    Hallman, D
    Burger, B
    Gupta, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) : 4753 - 4761
  • [44] A phase 2 study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric cancer
    Maurie Markman
    Journal of Cancer Research and Clinical Oncology, 1998, 124 : 353 - 353
  • [45] A phase 2 study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric cancer
    Markman, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (07) : 353 - 353
  • [46] Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: Results of a phase II study
    Constenla M.
    Garcia-Arroyo R.
    Lorenzo I.
    Carrete N.
    Campos B.
    Palacios P.
    Gastric Cancer, 2002, 5 (3) : 142 - 147
  • [47] ETOPOSIDE, LEUCOVORIN AND 5-FLUOROURACIL IN ADVANCED GASTRIC-CANCER - A PHASE-II STUDY
    VANCUTSEM, E
    FILEZ, L
    DEWYSPELAERE, J
    PENNINCKX, F
    JANSSENS, J
    ANTICANCER RESEARCH, 1995, 15 (03) : 1079 - 1080
  • [48] Phase II study of weekly paclitaxel, cisplatin, and 5-fluorouracil for advanced gastric cancer
    Takuo Hara
    Kazuhiro Nishikawa
    Mitsuaki Sakatoku
    Koji Oba
    Junichi Sakamoto
    Kenji Omura
    Gastric Cancer, 2011, 14 : 332 - 338
  • [49] Phase II study of weekly paclitaxel, cisplatin, and 5-fluorouracil for advanced gastric cancer
    Hara, Takuo
    Nishikawa, Kazuhiro
    Sakatoku, Mitsuaki
    Oba, Koji
    Sakamoto, Junichi
    Omura, Kenji
    GASTRIC CANCER, 2011, 14 (04) : 332 - 338
  • [50] Randomized, phase II study comparing cisplatin and high-dose 5-fluorouracil/leucovorin with paclitaxel and high-dose 5-fluorouracil/leucovorin in patients with advanced gastric cancer and adenocarcinomas of the gastroesophageal junction
    Tesselaar, M. E.
    Luelmo, S.
    Polee, M.
    van Bochove, A.
    Ouwerkerk, J.
    Pruijt, H.
    Sleeboom, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345